205 related articles for article (PubMed ID: 27233261)
1. Diagnostic Methods for CHIKV Based on Serological Tools.
Gaibani P; Landini MP; Sambri V
Methods Mol Biol; 2016; 1426():63-73. PubMed ID: 27233261
[TBL] [Abstract][Full Text] [Related]
2. Neutralization Assay for Chikungunya Virus Infection: Plaque Reduction Neutralization Test.
Azami NA; Moi ML; Takasaki T
Methods Mol Biol; 2016; 1426():273-82. PubMed ID: 27233280
[TBL] [Abstract][Full Text] [Related]
3. Enzyme-linked immunosorbent assay using recombinant envelope protein 2 antigen for diagnosis of Chikungunya virus.
Fumagalli MJ; de Souza WM; Espósito DLA; Silva A; Romeiro MF; Martinez EZ; da Fonseca BAL; Figueiredo LTM
Virol J; 2018 Jul; 15(1):112. PubMed ID: 30041676
[TBL] [Abstract][Full Text] [Related]
4. Development of a neutralization assay based on the pseudotyped chikungunya virus of a Korean isolate.
Chung WC; Hwang KY; Kang SJ; Kim JO; Song MJ
J Microbiol; 2020 Jan; 58(1):46-53. PubMed ID: 31768937
[TBL] [Abstract][Full Text] [Related]
5. Chikungunya Virus Growth and Fluorescent Labeling: Detection of Chikungunya Virus by Immunofluorescence Assay.
Moi ML; Takasaki T
Methods Mol Biol; 2016; 1426():143-52. PubMed ID: 27233268
[TBL] [Abstract][Full Text] [Related]
6. A potent neutralizing IgM mAb targeting the N218 epitope on E2 protein protects against Chikungunya virus pathogenesis.
Lam S; Nyo M; Phuektes P; Yew CW; Tan YJ; Chu JJ
MAbs; 2015; 7(6):1178-94. PubMed ID: 26305993
[TBL] [Abstract][Full Text] [Related]
7. High yield expression and purification of Chikungunya virus E2 recombinant protein and its evaluation for serodiagnosis.
Verma A; Chandele A; Nayak K; Kaja MK; Arulandu A; Lodha R; Ray P
J Virol Methods; 2016 Sep; 235():73-79. PubMed ID: 27180040
[TBL] [Abstract][Full Text] [Related]
8. Development of a pseudotyped-lentiviral-vector-based neutralization assay for chikungunya virus infection.
Kishishita N; Takeda N; Anuegoonpipat A; Anantapreecha S
J Clin Microbiol; 2013 May; 51(5):1389-95. PubMed ID: 23408687
[TBL] [Abstract][Full Text] [Related]
9. High rate of subclinical chikungunya virus infection and association of neutralizing antibody with protection in a prospective cohort in the Philippines.
Yoon IK; Alera MT; Lago CB; Tac-An IA; Villa D; Fernandez S; Thaisomboonsuk B; Klungthong C; Levy JW; Velasco JM; Roque VG; Salje H; Macareo LR; Hermann LL; Nisalak A; Srikiatkhachorn A
PLoS Negl Trop Dis; 2015 May; 9(5):e0003764. PubMed ID: 25951202
[TBL] [Abstract][Full Text] [Related]
10. Antigenic Variation of East/Central/South African and Asian Chikungunya Virus Genotypes in Neutralization by Immune Sera.
Chua CL; Sam IC; Merits A; Chan YF
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004960. PubMed ID: 27571254
[TBL] [Abstract][Full Text] [Related]
11. Serological Responses in Patients Infected with Mayaro Virus and Evaluation of Cross-Protective Responses against Chikungunya Virus.
Bopp NE; Jencks KJ; Siles C; Guevara C; Vilcarromero S; Fernández D; Halsey ES; Ampuero JS; Aguilar PV
Am J Trop Med Hyg; 2021 Nov; 106(2):607-609. PubMed ID: 34844213
[TBL] [Abstract][Full Text] [Related]
12. Virus replicon particle based Chikungunya virus neutralization assay using Gaussia luciferase as readout.
Gläsker S; Lulla A; Lulla V; Couderc T; Drexler JF; Liljeström P; Lecuit M; Drosten C; Merits A; Kümmerer BM
Virol J; 2013 Jul; 10():235. PubMed ID: 23855906
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Two Enzyme-Linked Immunosorbent Assay Kits for Chikungunya Virus IgM Using Samples from Deceased Organ and Tissue Donors.
Prince HE; Altrich ML; Nowicki MJ
Clin Vaccine Immunol; 2016 Oct; 23(10):825-830. PubMed ID: 27535838
[TBL] [Abstract][Full Text] [Related]
14. Pre-existing chikungunya virus neutralizing antibodies correlate with risk of symptomatic infection and subclinical seroconversion in a Philippine cohort.
Yoon IK; Srikiatkhachorn A; Alera MT; Fernandez S; Cummings DAT; Salje H
Int J Infect Dis; 2020 Jun; 95():167-173. PubMed ID: 32247051
[TBL] [Abstract][Full Text] [Related]
15. Laboratory Diagnosis of Chikungunya Virus Infections and Commercial Sources for Diagnostic Assays.
Johnson BW; Russell BJ; Goodman CH
J Infect Dis; 2016 Dec; 214(suppl 5):S471-S474. PubMed ID: 27920176
[TBL] [Abstract][Full Text] [Related]
16. Combining anti-IgM and IgG immunoassays for comprehensive chikungunya virus diagnostic testing.
Mendoza EJ; Robinson A; Dimitrova K; Mueller N; Holloway K; Makowski K; Wood H
Zoonoses Public Health; 2019 Dec; 66(8):909-917. PubMed ID: 31449360
[TBL] [Abstract][Full Text] [Related]
17. Chikungunya virus envelope-specific human monoclonal antibodies with broad neutralization potency.
Warter L; Lee CY; Thiagarajan R; Grandadam M; Lebecque S; Lin RT; Bertin-Maghit S; Ng LF; Abastado JP; Desprès P; Wang CI; Nardin A
J Immunol; 2011 Mar; 186(5):3258-64. PubMed ID: 21278338
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against chikungunya virus.
Kumar M; Sudeep AB; Arankalle VA
Vaccine; 2012 Sep; 30(43):6142-9. PubMed ID: 22884660
[TBL] [Abstract][Full Text] [Related]
19. A neutralization assay for chikungunya virus infections in a multiplex format.
Weber C; König R; Niedrig M; Emmerich P; Schnierle BS
J Virol Methods; 2014 Jun; 201():7-12. PubMed ID: 24552952
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic accuracy of serological tests for the diagnosis of Chikungunya virus infection: A systematic review and meta-analysis.
Andrew A; Navien TN; Yeoh TS; Citartan M; Mangantig E; Sum MSH; Ch'ng ES; Tang TH
PLoS Negl Trop Dis; 2022 Feb; 16(2):e0010152. PubMed ID: 35120141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
